Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,006
Views
29
CrossRef citations to date
0
Altmetric
Back Matter

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Ieva Saulitea Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland;b Department of Dermatology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandView further author information
,
Desislava Ignatovaa Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Yun-Tsan Changa Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Christina Fassnachta Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Florentia Dimitrioua Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Eleni Varypatakia Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Florian Anzengrubera Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Mirjam Nägelia Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Antonio Cozziob Department of Dermatology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandView further author information
,
Reinhard Dummera Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Julia Scarisbrickc Department of Dermatology, University Hospitals Birmingham, Birmingham, UKView further author information
,
Steve Pascoloa Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandView further author information
,
Wolfram Hoetzeneckerd Department of Dermatology, Kepler University Hospital, Linz, AustriaView further author information
,
Malgorzata Bobrowicze Department of Immunology, Medical University of Warsaw, Warsaw, PolandView further author information
&
Emmanuella Guenovaa Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland;f Department of Dermatology, Lausanne University Hospital CHUV, University of Lausanne, Lausanne, SwitzerlandCorrespondence[email protected]
View further author information
 show all
Article: 1738797 | Received 02 Jul 2019, Accepted 09 Jan 2020, Published online: 18 Mar 2020

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ari Pelcovits, Thomas A Ollila & Adam J Olszewski. (2023) Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma. Cancer Management and Research 15, pages 989-998.
Read now
Tianying Su, George E. Duran, Alexa C. Kwang, Nirasha Ramchurren, Steven P. Fling, Youn H. Kim & Michael S. Khodadoust. (2022) Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome. OncoImmunology 11:1.
Read now
Christoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, Christina Fassnacht, Florentia Dimitriou, Mirjam Nägeli, Steve Pascolo, Wolfram Hoetzenecker, Malgorzata Bobrowicz & Emmanuella Guenova. (2021) Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome. OncoImmunology 10:1.
Read now

Articles from other publishers (26)

Megan E. Gumina, Madeline J. Hooper, Xiaolong A. Zhou & Sergei B. Koralov. (2023) Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas. Journal of Investigative Dermatology.
Crossref
Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, Robert Gniadecki, Emmilia Hodak, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Stephen Morrris, Jan P. Nicolay, Pablo L. Ortiz-Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H. Vermeer, Ulrike Wehkamp, Sean Whittaker, Rein Willemze & Franz Trautinger. (2023) EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023. European Journal of Cancer 195, pages 113343.
Crossref
Yi-Chien Tsai, Tanja Schlaepfer, Desislava Ignatova, Yun-Tsan Chang, Alan Valaperti, Boyko Amarov, Gabriela Blanchard, Kevin Pehr, Maya Vonow-Eisenring, Mirjana Urosevic-Maiwald, Wolfram Hoetzenecker, Steve Pascolo, Christoph Iselin, Christina  Fassnacht, Florentia Dimitriou, Malgorzata Bobrowicz & Emmanuella Guenova. (2023) Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma. British Journal of Dermatology 189:5, pages 603-611.
Crossref
Yumei Gao, Simeng Hu, Ruoyan Li, Shanzhao Jin, Fengjie Liu, Xiangjun Liu, Yingyi Li, Yicen Yan, Weiping Liu, Jifang Gong, Shuxia Yang, Ping Tu, Lin Shen, Fan Bai & Yang Wang. (2023) Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment. JCI Insight 8:4.
Crossref
Michael S. Khodadoust, Eric Mou & Youn H. Kim. (2023) Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome. Blood 141:7, pages 695-703.
Crossref
Christopher J. Fay, Katherine C. Awh, Nicole R. LeBoeuf & Cecilia A. Larocca. (2023) Harnessing the immune system in the treatment of cutaneous T cell lymphomas. Frontiers in Oncology 12.
Crossref
Yuru Chen, Jiazheng Sun, Yachan Luo, Jiazhou Liu, Xiaoyu Wang, Rui Feng, Jing Huang, Huimin Du, Qin Li, Jinxiang Tan, Guosheng Ren, Xiaoyi Wang & Hongzhong Li. (2022) Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. Journal of Translational Medicine 20:1.
Crossref
Rony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, Sharon Merims, Emma Hajaj, Jonathan E. Cohen, Shiri Klein, Shoshana Frankenburg, Lilach Moyal, Emilia Hodak, Abraham Zlotogorski & Michal Lotem. (2022) The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma. Immunologic Research 70:6, pages 793-799.
Crossref
Amy Xiao & Oleg E. Akilov. (2022) Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma. Cells 11:22, pages 3591.
Crossref
Camille Luherne, Sarah Menguy, Thomas Ferte, Marie Beylot-Barry, Julien Seneschal, Brigitte Milpied, Jean-Philippe Vial, Audrey Gros, Samuel Amintas, Béatrice Vergier & Anne Pham-Ledard. (2022) A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma. Acta Dermato-Venereologica 102, pages adv00773.
Crossref
Tony T. Jiang, Oleg Kruglov, Larisa Geskin & Oleg E. Akilov. (2022) Repetitive expanded T‐cell receptor clonotypes impart the classic T helper 2 Sézary cell phenotype. British Journal of Dermatology 187:2, pages 265-267.
Crossref
Fernando Gallardo, Evelyn Andrades, Arnau Iglesias, Jessica González, Laura Solé, Yolanda Guillén, Gonzalo Blanco, Luis Colomo, Eva Gimeno, David Conde, Eva Rodriguez, Isabel Bielsa-Marso, Mar Iglesias, Beatriz Bellosillo, Ramon M. Pujol, José R. Regueiro, Anna Bigas & Lluís Espinosa. (2022) Sézary syndrome patient–derived models allow drug selection for personalized therapy. Blood Advances 6:11, pages 3410-3421.
Crossref
Tomomitsu MIYAGAKI. (2022) Immune Checkpoint Molecules and Co-stimulatory Molecules in Cutaneous T-cell Lymphoma皮膚 T 細胞リンパ腫における免疫チェックポイント分子・共刺激分子. Nishi Nihon Hifuka 84:3, pages 187-193.
Crossref
Natasha E. Lewis, Qi Gao, Kseniya Petrova‐Drus, Melissa Pulitzer, Allison Sigler, Jeeyeon Baik, Alison J. Moskowitz, Steven M. Horwitz, Ahmet Dogan & Mikhail Roshal. (2022) PD ‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome . Cytometry Part B: Clinical Cytometry 102:3, pages 189-198.
Crossref
Gerd Jomrich, Dagmar Kollmann, Dariga Ramazanova, Robin Ristl, Richard P. Grose, Aysegül Ilhan-Mutlu, Matthias Preusser, Christina Fassnacht, Yi-Chien Tsai, Emmanuella Guenova & Sebastian F. Schoppmann. (2022) Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment. European Journal of Surgical Oncology 48:2, pages 383-390.
Crossref
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, Kelly Cristina Gomes Manfrere, Maria Notomi Sato & José Antonio Sanches. (2022) The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome. International Journal of Molecular Sciences 23:2, pages 936.
Crossref
Yun-Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, Steve Pascolo, Christina Fassnacht & Emmanuella Guenova. (2022) Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions. JID Innovations 2:1, pages 100069.
Crossref
Guranda Chitadze, Ulrike Wehkamp, Ottmar Janssen, Monika Brüggemann & Marcus Lettau. (2021) The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells. Cancers 13:23, pages 5947.
Crossref
Constanze Jonak, Julia Tittes, Patrick Manfred Brunner & Emmanuella Guenova. (2021) Mycosis fungoides und Sézary‐Syndrom. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:9, pages 1307-1335.
Crossref
Constanze Jonak, Julia Tittes, Patrick Manfred Brunner & Emmanuella Guenova. (2021) Mycosis fungoides and Sézary syndrome. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:9, pages 1307-1334.
Crossref
Reinhard Dummer, Maarten H. Vermeer, Julia J. Scarisbrick, Youn H. Kim, Connor Stonesifer, Cornelis P. Tensen, Larisa J. Geskin, Pietro Quaglino & Egle Ramelyte. (2021) Cutaneous T cell lymphoma. Nature Reviews Disease Primers 7:1.
Crossref
Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, Alessandro Pileri, Alba Guglielmo, Luca Tonella, Martina Sanlorenzo, Simone Ribero, Maria Teresa Fierro & Pietro Quaglino. (2021) Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives. Frontiers in Oncology 11.
Crossref
Marina Tusup, Severin Läuchli, Natalia Teresa Jarzebska, Lars E. French, Yun-Tsan Chang, Maya Vonow-Eisenring, Andreas Su, Thomas M. Kündig, Emmanuella Guenova & Steve Pascolo. (2021) mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma. Pharmaceutics 13:7, pages 1040.
Crossref
Joseph S. Durgin, David M. Weiner, Maria Wysocka & Alain H. Rook. (2021) The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication. Journal of the American Academy of Dermatology 84:3, pages 587-595.
Crossref
Maria Grazia Narducci, Anna Tosi, Alessandra Frezzolini, Enrico Scala, Francesca Passarelli, Laura Bonmassar, Alessandro Monopoli, Maria Pina Accetturi, Maria Cantonetti, Gian Carlo Antonini Cappellini, Federica De Galitiis, Antonio Rosato, Mario Picozza, Giandomenico Russo & Stefania D’Atri. (2020) Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab. Frontiers in Immunology 11.
Crossref
Malgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, Yun-Tsan Chang, Florentia Dimitriou & Emmanuella Guenova. (2020) Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020. International Archives of Allergy and Immunology 181:10, pages 733-745.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.